Clinical Trial Update: A Study of PM1022 in Patients With Advanced Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial investigating PM1022 in patients with advanced tumors; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumors

Drugs mentioned

• PM1022

Snippet

Sponsor: Biotheus Inc. | Conditions: Advanced Tumors | Phase 1, Phase 2 | Status: UNKNOWN